Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Cancer Antibody Drug Conjugates Market Research Report 2012-2024

  • HEY2876546
  • 82 Pages
  • January 2019
  • Healthcare
Download Sample    Get Discount   
 

The global Cancer Antibody Drug Conjugates market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

First & Second Generation ADCs

Third Generation ADCs

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Novartis

Merck

Roche

AbbVie

UCB

Bristol-Myers Squibb

Stem CentRx

Biogen Idec

Nordic Nanovector

Millennium

Biotest AG

PDL BioPharma

Progenics Pharmaceuticals

Seattle Genetics

Viventia Biotechnologies

AbGenomics Corporation

Helix BioPharma

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Hospitals

Clinics

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 First & Second Generation ADCs

1.2.1.2 Third Generation ADCs

1.2.2 by Application

1.2.2.1 Hospitals

1.2.2.2 Clinics

1.2.2.3 Others

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 First & Second Generation ADCs Market, 2013-2018

4.1.2 Third Generation ADCs Market, 2013-2018

4.2 Market Forecast

4.2.1 First & Second Generation ADCs Market Forecast, 2019-2023

4.2.2 Third Generation ADCs Market Forecast, 2019-2023

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Hospitals Market, 2013-2018

5.1.2 Clinics Market, 2013-2018

5.1.3 Others Market, 2013-2018

5.2 Market Forecast

5.2.1 Hospitals Market Forecast, 2019-2023

5.2.2 Clinics Market Forecast, 2019-2023

5.2.3 Others Market Forecast, 2019-2023

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2018

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2018

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2018

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2018

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2018

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2019-2024

6.2.2 North America Market Forecast, 2019-2024

6.2.3 Europe Market Forecast, 2019-2024

6.2.4 South America Market Forecast, 2019-2024

6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Novartis

8.2 Merck

8.3 Roche

8.4 AbbVie

8.5 UCB

8.6 Bristol-Myers Squibb

8.7 Stem CentRx

8.8 Biogen Idec

8.9 Nordic Nanovector

8.10 Millennium

8.11 Biotest AG

8.12 PDL BioPharma

8.13 Progenics Pharmaceuticals

8.14 Seattle Genetics

8.15 Viventia Biotechnologies

8.16 AbGenomics Corporation

8.17 Helix BioPharma

9 Conclusion

Table Product Specifications of Cancer Antibody Drug Conjugates

Table Products Segment of Cancer Antibody Drug Conjugates

Table First & Second Generation ADCs Overview

Table Third Generation ADCs Overview

Table Global Cancer Antibody Drug Conjugates Market by Type, 2011-2022 (USD Million)

Table Application Segment of Cancer Antibody Drug Conjugates

Table Hospitals Overview

Table Clinics Overview

Table Others Overview

Table Global Cancer Antibody Drug Conjugates Market by Application, 2011-2022 (USD Million)

Table Global Cancer Antibody Drug Conjugates Market by Region, 2011-2022 (USD Million)

Table Cost of Cancer Antibody Drug Conjugates

Table Market Dynamics

Table Policy of Cancer Antibody Drug Conjugates

Table GDP of Major Countries

Table First & Second Generation ADCs CAGR by Revenue and Volume, 2012-2018

Table Third Generation ADCs CAGR by Revenue and Volume, 2012-2018

Table First & Second Generation ADCs CAGR by Revenue and Volume, 2012-2022

Table Third Generation ADCs CAGR by Revenue and Volume, 2012-2022

Table Hospitals CAGR by Revenue and Volume, 2012-2018

Table Clinics CAGR by Revenue and Volume, 2012-2018

Table Others CAGR by Revenue and Volume, 2012-2018

Table Global Cancer Antibody Drug Conjugates Market by Vendors, 2012-2018 (USD Million)

Table Global Cancer Antibody Drug Conjugates Market by Vendors, 2012-2018 (in Volume)

Table Global Cancer Antibody Drug Conjugates Market Share by Vendors, 2012-2018 (USD Million)

Table Global Cancer Antibody Drug Conjugates Market Share by Vendors, 2012-2018 (in Volume)

Table Price Factors List

Table Novartis Profile List

Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Profile List

Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Profile List

Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AbbVie Profile List

Table Microecological Modulator Operating Data of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table UCB Profile List

Table Microecological Modulator Operating Data of UCB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Profile List

Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Stem CentRx Profile List

Table Microecological Modulator Operating Data of Stem CentRx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biogen Idec Profile List

Table Microecological Modulator Operating Data of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Nordic Nanovector Profile List

Table Microecological Modulator Operating Data of Nordic Nanovector (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Millennium Profile List

Table Microecological Modulator Operating Data of Millennium (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biotest AG Profile List

Table Microecological Modulator Operating Data of Biotest AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table PDL BioPharma Profile List

Table Microecological Modulator Operating Data of PDL BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Progenics Pharmaceuticals Profile List

Table Microecological Modulator Operating Data of Progenics Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Seattle Genetics Profile List

Table Microecological Modulator Operating Data of Seattle Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Viventia Biotechnologies Profile List

Table Microecological Modulator Operating Data of Viventia Biotechnologies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AbGenomics Corporation Profile List

Table Microecological Modulator Operating Data of AbGenomics Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Helix BioPharma Profile List

Table Microecological Modulator Operating Data of Helix BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370